Advanced search
1 file | 704.28 KB

Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia

Pieter Hindryckx (UGent) , Lindsey Devisscher (UGent) , Debby Laukens (UGent) , Koen Venken (UGent) , Harald Peeters (UGent) and Martine De Vos (UGent)
(2011) LABORATORY INVESTIGATION. 91(9). p.1266-1276
Author
Organization
Abstract
Intestinal inflammation is associated with enhanced mucosal hypoxia, which contributes to the ongoing inflammatory process and hampers appropriate mucosal healing. We questioned whether local treatment with an oxygen (O(2))-carrying and -releasing molecule (oxygenated perfluorodecalin, O(2)-PFD) could positively influence the course of experimental colitis. The impact of intrarectal (IR) treatment with O(2)-PFD was tested using the murine dextran sodium sulfate (DSS)-induced model of distal colitis, both in preventive and therapeutic settings. Colonic mucosal hypoxia was visualized by pimonidazole staining. Colonic permeability was evaluated with FITC-dextran. In the preventive study, mice treated with O(2)-PFD were protected against DSS colitis compared with saline-treated mice, as demonstrated by reduced shortening of colon length, reduced colonic tumor necrosis factor-alpha levels and a lower histological inflammation score (P<0.05 for all parameters). In the therapeutic study, administration of O(2)-PFD resulted in accelerated recovery of colitis compared with saline-treated littermates, and this was reflected by a better weight evolution, lower myeloperoxidase activity and a lower histological inflammation score (P<0.05 for all parameters). It was found that O(2)-PFD established its therapeutic effects through (1) intrinsic anti-inflammatory effects of the PFD molecule and (2) O(2)-induced preservation and healing of the intestinal epithelial surface. Further in vitro and in vivo studies showed that the barrier-protective activity of O(2)-PFD was obtained through prevention of colonocyte apoptosis and stimulation of colonocyte proliferation during inflammatory hypoxia. These data show that IR treatment with O(2)-PFD promotes colitis healing by the combined actions of direct anti-inflammatory effects and O(2)-induced restitution of the epithelial barrier. As such, O(2)-PFD enemas could be an attractive treatment option for patients with distal inflammatory bowel disease.
Keywords
experimental colitis, intestinal epithelium, mucosal hypoxia, perfluorodecalin, EPITHELIAL-CELL APOPTOSIS, NECROSIS-FACTOR-ALPHA, HYPERBARIC-OXYGEN, CROHNS-DISEASE, BIOMEDICAL APPLICATIONS, TNF-ALPHA, INJURY, ISCHEMIA, CARRIERS, RAT

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 704.28 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Hindryckx, Pieter, Lindsey Devisscher, Debby Laukens, Koen Venken, Harald Peeters, and Martine De Vos. 2011. “Intrarectal Administration of Oxygenated Perfluorodecalin Promotes Healing of Murine Colitis by Targeting Inflammatory Hypoxia.” Laboratory Investigation 91 (9): 1266–1276.
APA
Hindryckx, P., Devisscher, L., Laukens, D., Venken, K., Peeters, H., & De Vos, M. (2011). Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia. LABORATORY INVESTIGATION, 91(9), 1266–1276.
Vancouver
1.
Hindryckx P, Devisscher L, Laukens D, Venken K, Peeters H, De Vos M. Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia. LABORATORY INVESTIGATION. 2011;91(9):1266–76.
MLA
Hindryckx, Pieter, Lindsey Devisscher, Debby Laukens, et al. “Intrarectal Administration of Oxygenated Perfluorodecalin Promotes Healing of Murine Colitis by Targeting Inflammatory Hypoxia.” LABORATORY INVESTIGATION 91.9 (2011): 1266–1276. Print.
@article{1940056,
  abstract     = {Intestinal inflammation is associated with enhanced mucosal hypoxia, which contributes to the ongoing inflammatory process and hampers appropriate mucosal healing. We questioned whether local treatment with an oxygen (O(2))-carrying and -releasing molecule (oxygenated perfluorodecalin, O(2)-PFD) could positively influence the course of experimental colitis. The impact of intrarectal (IR) treatment with O(2)-PFD was tested using the murine dextran sodium sulfate (DSS)-induced model of distal colitis, both in preventive and therapeutic settings. Colonic mucosal hypoxia was visualized by pimonidazole staining. Colonic permeability was evaluated with FITC-dextran. In the preventive study, mice treated with O(2)-PFD were protected against DSS colitis compared with saline-treated mice, as demonstrated by reduced shortening of colon length, reduced colonic tumor necrosis factor-alpha levels and a lower histological inflammation score (P{\textlangle}0.05 for all parameters). In the therapeutic study, administration of O(2)-PFD resulted in accelerated recovery of colitis compared with saline-treated littermates, and this was reflected by a better weight evolution, lower myeloperoxidase activity and a lower histological inflammation score (P{\textlangle}0.05 for all parameters). It was found that O(2)-PFD established its therapeutic effects through (1) intrinsic anti-inflammatory effects of the PFD molecule and (2) O(2)-induced preservation and healing of the intestinal epithelial surface. Further in vitro and in vivo studies showed that the barrier-protective activity of O(2)-PFD was obtained through prevention of colonocyte apoptosis and stimulation of colonocyte proliferation during inflammatory hypoxia. These data show that IR treatment with O(2)-PFD promotes colitis healing by the combined actions of direct anti-inflammatory effects and O(2)-induced restitution of the epithelial barrier. As such, O(2)-PFD enemas could be an attractive treatment option for patients with distal inflammatory bowel disease.},
  author       = {Hindryckx, Pieter and Devisscher, Lindsey and Laukens, Debby and Venken, Koen and Peeters, Harald and De Vos, Martine},
  issn         = {0023-6837},
  journal      = {LABORATORY INVESTIGATION},
  keyword      = {experimental colitis,intestinal epithelium,mucosal hypoxia,perfluorodecalin,EPITHELIAL-CELL APOPTOSIS,NECROSIS-FACTOR-ALPHA,HYPERBARIC-OXYGEN,CROHNS-DISEASE,BIOMEDICAL APPLICATIONS,TNF-ALPHA,INJURY,ISCHEMIA,CARRIERS,RAT},
  language     = {eng},
  number       = {9},
  pages        = {1266--1276},
  title        = {Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine colitis by targeting inflammatory hypoxia},
  url          = {http://dx.doi.org/10.1038/labinvest.2011.102},
  volume       = {91},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: